Leveraging advanced methods to evaluate AI-Pharma companies
- 22/05/2019
The level of sophistication used in due diligence should be on par with the level of complexity in a given industry. AI-Pharma companies are 100 times as complex as FinTech companies. Methodologies used to assess them should be 100 times as rigorous. Discovering new drugs using AI is one of the most challenging areas in biological sciences. Top tier AI for Drug Discovery companies
READ MORE